“…However, in cancer cells, two scenarios have been shown: A pro-oxidant activity in which melatonin induces the increase of intracellular levels of ROS, leading to cell death, as was shown in the present study and by others [ 26 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 ]; and melatonin reducing intracellular levels of ROS and inducing cell death by different mechanisms, such as, for example, inhibiting the nuclear transcription factor kappa B (NF-κB) nuclear activity, as reported in human glioma cells (T98 and U251) by Wang and colleagues [ 55 ], and in rat glioma cells (C6) by Martín and colleagues [ 56 ]. Otherwise, the melatonin activation of NF-κB has also been associated with an increase in intracellular oxidative stress in a model of human monocyte (U937) culture [ 47 , 48 ], and in a primary cerebellar granule cell culture [ 57 ]. In the present study, a known antioxidant, NAC, completely inhibited the decreased viability induced by 1 mM melatonin in a U87MG cell culture.…”